🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

While awaiting the results of milvexian in the ongoing LIBREXIA-ACS trial, we conducted a pilot study in STEMI patients, revealing a significant increase in FXIa levels from admission to discharge in those undergoing primary PCI. This finding may have implications for the optimal

Happy to share our latest findings on tricuspid valve repair in REC Publications under the great mentorship of Xavier Freixa ! 💡 T-TEER emerges as an effective strategy for patients with CIED-associated TR 🔥 sciencedirect.com/science/articl… Thanks to the entire Team!!

thanks for inviting us to share with you our tips&tricks in #CHIP zero-contrast #PCI. a special thank to our nurse team whose contribution behind the scene is not always visible PCRonline 🫀 SACIS Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 MIЯVΛƬ #IC Nouf Alanazi 🇸🇦 Hospital Clínic IDIBAPS barnaclínic+

🚨Our latest JAHA paper 🚨 published in the #GoRedForWomen issue highlighting 🔬 sex-specific differences in the prognostic role of ACh testing! 👨Men ACh+: ↑ MACE 👩Women ACh+: ↑ Angina recurrence 📖 Open Access (link in comments 👇) Rocco Montone EHJ Editor-in-Chief FRANCESCO BURZOTTA

#DCB as the default strategy for #ISR? Open question. Concerns remain when evaluating available RCTs: reliability of TLR as a metric to measure efficacy of the treatment, outdated cohorts with no standardized procedural steps, and minimal use of intravascular imaging. #CRT25

This study highlights sex-related differences in acetylcholine testing, paving the way for personalized care in INOCA and MINOCA patients. #AHAJournals #GoRedforWomen #JAHASpotlight Riccardo Rinaldi Università Cattolica Rocco Montone ahajrnls.org/3FpJMhd

🫀 La división de #CardiologíaIntervencionista ha estado presente en el #CSCestructural, la reunión de referencia en la especialidad desde un punto de vista práctico. En concreto, ha apoyado un caso en vivo de #TAVI realizado desde el Hospital Clínic por el Dr. Ander Regueiro.

COVADIS criteria during acetylcholine testing provide prognostic insight in INOCA and MINOCA. Epicardial vasoconstriction emerges as a key risk indicator. Read the paper by Riccardo Rinaldi Rocco Montone here: 🔗 ow.ly/5Y9350VjOe5 #INOCA #MINOCA #Cardiology #COVADIS #EAPCI

Can #PCFS guide risk stratification after #PCI? Could it provide additional info for the guidance of antithrombotic therapy beyond #PFTs? The sweet spot is still missing—but we’re getting closer. In this JACC Journals editorial, my perspective. sciencedirect.com/science/articl…

We shared some thoughts on potential sex-related differences in #TAVI. Despite ongoing underrepresentation of women in clinical trials, the trend is slowly shifting in this field. Grateful to Ander Regueiro for supporting me along this way.

when I was a medical student, I remained so fascinated by Attilio Maseri and his "hidden side of the moon" that I decided to study cardiology working on two successful research projects on inflammation and atherosclerosis for my MD and Cardiology degrees. I have very happy that

Beyond #LDL, #inflammation is a key driver of coronary atherosclerosis and #ACS risk. #Imaging tools provide valuable insights, and emerging #therapies are on the road. Optimal #timing and patient selection remain major challenges. heart.bmj.com/cgi/rapidpdf/h…

Great and sharp statistics lesson from Daniele Giacoppo on the design and results of the HOST-BR trial.

Excited to share our review on of catheter-based techniques for Pulmonary Embolism: a step-by-step guide full of practical insights into procedural planning, device selection, and technical execution 🔗 Read the full article EuroIntervention here: eurointervention.pcronline.com/article/cathet… 🧵⬇️

We present an #unusual case of angiographically severe #ISR with aneurysmal vessel remodeling of the #RCA 5 years after #PCI due to #CTO. #IVUS provided crucial insights (#videos available) authors.elsevier.com/a/1l3Ih6uPJvyJ…

🚨 Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection? ⬇️ 📌 In this clinical focus, Marco Spagnolo and Davide Capodanno review the potential role of FXI Inhibitors in pts with #MI 👉 thieme-connect.de/products/ejour… Author's interview below ⬇️

Diferencias de sexo en pacientes sometidos a recambio valvular aórtico: una historia de dos corazones #REC #AheadOfPrint Giovanni Occhipinti Ander Regueiro revespcardiol.org/es-diferencias…

With almost 12,000 patients undergoing Light Trasmission Aggregometry over 20 years, this study is among the largest exploring sex-related variability in platelet reactivity, highlighting potential implications for personalized antiplatelet therapy. bit.ly/4kGEdu4

#INOCA patients showed significantly lower platelet-related thrombus formation vs Obstructive CAD. These findings suggest a different thrombotic risk profile and challenge routine antiplatelet use in #INOCA. 📖 Full article in #JACC: sciencedirect.com/science/articl… Giovanni Occhipinti